- Home
- CDIO vs EDSA Comparison
CDIO vs EDSA Comparison
Compare CDIO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- EDSA
- Stock Information
- Founded
- CDIO 2017
- EDSA 2015
- Country
- CDIO United States
- EDSA Canada
- Employees
- CDIO N/A
- EDSA N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- EDSA Health Care
- Exchange
- CDIO Nasdaq
- EDSA Nasdaq
- Market Cap
- CDIO 12.4M
- EDSA 11.0M
- IPO Year
- CDIO N/A
- EDSA N/A
- Fundamental
- Price
- CDIO $0.26
- EDSA $2.24
- Analyst Decision
- CDIO Buy
- EDSA Strong Buy
- Analyst Count
- CDIO 1
- EDSA 1
- Target Price
- CDIO $2.00
- EDSA $21.00
- AVG Volume (30 Days)
- CDIO 5.4M
- EDSA 49.4K
- Earning Date
- CDIO 11-13-2024
- EDSA 12-13-2024
- Dividend Yield
- CDIO N/A
- EDSA N/A
- EPS Growth
- CDIO N/A
- EDSA N/A
- EPS
- CDIO N/A
- EDSA N/A
- Revenue
- CDIO $39,138.00
- EDSA N/A
- Revenue This Year
- CDIO $2,093.61
- EDSA N/A
- Revenue Next Year
- CDIO $43.05
- EDSA N/A
- P/E Ratio
- CDIO N/A
- EDSA N/A
- Revenue Growth
- CDIO 1363.10
- EDSA N/A
- 52 Week Low
- CDIO $0.19
- EDSA $2.11
- 52 Week High
- CDIO $3.56
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- CDIO 45.30
- EDSA 22.56
- Support Level
- CDIO $0.21
- EDSA $2.11
- Resistance Level
- CDIO $0.52
- EDSA $2.44
- Average True Range (ATR)
- CDIO 0.06
- EDSA 0.25
- MACD
- CDIO -0.00
- EDSA -0.05
- Stochastic Oscillator
- CDIO 6.27
- EDSA 8.18
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.